Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pyrimidine Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114369124A reveals a novel 4-step synthesis for 2'-substituted pyrimidine nucleosides, offering high purity and scalable manufacturing for nucleic acid drugs.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Patent CN105693627A reveals efficient Ru-pheox catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102127135B reveals a mild gold-catalyzed glycosylation method for nucleoside intermediates, offering superior regioselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN102127135A reveals a mild, gold-catalyzed glycosylation method for pyrimidine and purine nucleosides, offering significant cost reduction in API manufacturing.
Patent CN102603652A reveals a mild three-step synthesis for 5-formylpyrimidine carbocyclic nucleosides, offering a reliable route for antiviral intermediate manufacturing.
Patent CN108314655A enables high-purity chiral nucleoside synthesis with 99% ee, reducing API manufacturing costs and ensuring reliable supply chain for pharmaceutical intermediates.